Hairy cell leukemia variant, a new entity of the WHO 2008

Journal of Clinical Oncology

Volumn 29, Issue 36, 2011, Pages

  Wang, Xiaoqiong ^a,b   Spielberger, Ricardo ^a,c   Huang, Qin ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANTIBIOTIC AGENT; CD19 ANTIGEN; CD22 ANTIGEN; CD79A ANTIGEN; GLYCOPROTEIN P 15095; KI 67 ANTIGEN; LEUKOSIALIN; PENTOSTATIN; TRANSCRIPTION FACTOR PAX5;

ADULT; ANEMIA; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; BASOPHILIA; BONE MARROW BIOPSY; CASE REPORT; CELL INFILTRATION; CHROMOSOME ADDITION; CHROMOSOME DELETION; CYTOGENETICS; FLOW CYTOMETRY; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSPLENISM; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KARYOTYPE 46,XY; LEUKOCYTOSIS; MALE; MONONUCLEAR CELL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTOPENIA;

GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; WORLD HEALTH ORGANIZATION;

EID: 84555218431     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.8497     Document Type: Article

References (23)

1. Piris M, Foucar K, Mollejo M, et al: Splenic B-cell lymphoma/leukaemia, unclassifiable, in Swerdlow SH, Campo E, Harris NL, et al (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France, 2008, pp 191-193
2. Robak T: Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment. Cancer Treat Rev 37:3-10, 2011
3. Cawley JC, Burns GF, Hayhoe FG: A chronic lymphoproliferative disorder with distinctive features: A distinct variant of hairy-cell leukaemia. Leuk Res 4:547-559, 1980 (Pubitemid 11207672)
4. Foucar K, Catovsky D: Hairy cell leukaemia, in Jaffe E, Harris NL, Stein H, et al (eds): Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues - World Health Organization Classification of Tumours. IARC Press, Lyon France, 2001, pp 138-141
5. Traverse-Glehen A, Baseggio L, Callet-Bauchu E, et al: Hairy cell leukaemia-variant and splenic red pulp lymphoma: A single entity? Br J Haematol 150:113-116, 2010
6. Forconi F, Sahota SS, Raspadori D, et al: Hairy cell leukemia: At the crossroad of somatic mutation and isotype switch. Blood 104:3312-3317, 2004 (Pubitemid 39507151)
7. Hockley SL, Giannouli S, Morilla A, et al: Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns. Br J Haematol 148:666-669, 2010
8. Hockley SL, Morilla A, Else M, et al: Higher expression levels of activation-induced cytidine deaminase distinguish hairy cell leukemia from hairy cell leukemia-variant and splenic marginal zone lymphoma. Leukemia 24:1084-1086, 2010
9. Arons E, Roth L, Sapolsky J, et al: Evidence of canonical somatic hypermutation in hairy cell leukemia. Blood 117:4844-4851, 2011
10. Hockley SL, Morgan GJ, Leone PE, et al: High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia. Leukemia 25:1189-1192, 2011
11. Cessna MH, Hartung L, Tripp S, et al: Hairy cell leukemia variant: Fact or fiction. Am J Clin Pathol 123:132-138, 2005 (Pubitemid 40066180)
12. Arons E, Suntum T, Stetler-Stevenson M, et al: VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood 114:4687-4695, 2009
13. Robak T: Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treat Rev 32:365-376, 2006
14. Matutes E, Wotherspoon A, Brito-Babapulle V, et al: The natural history and clinico-pathological features of the variant form of hairy cell leukemia. Leukemia 15:184-186, 2001 (Pubitemid 32124084)
15. Zinzani PL, Lauria F, Buzzi M, et al: Hairy cell leukemia variant: A morphologic, immunologic and clinical study of 7 cases. Haematologica 75:54-57, 1990 (Pubitemid 20138537)
16. Dunphy CH, Petruska PJ: Atypical prolymphocytic variant of hairy-cell leukemia: Case report and review of the literature. Am J Hematol 53:121-125, 1996 (Pubitemid 26377699)
17. Fietz T, Rieger K, Schmittel A, et al: Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment. Hematol J 5:451-452, 2004 (Pubitemid 39359285)
18. Quach H, Januszewicz H, Westerman D: Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab. Haematologica 90:ECR26, 2005 (suppl)
19. Quigley MM, Bethel KJ, Sharpe RW, et al: CD52 expression in hairy cell leukemia. Am J Hematol 74:227-230, 2005
20. Kreitman RJ, Pastan I: Immunobiological treatments of hairy-cell leukaemia. Best Pract Res Clin Haematol 16:117-133, 2003
21. Kreitman RJ, Tallman MS, Coutre S, et al: Phase I dose-escalation study of CAT-8015 (HA22), a CD22-specific targeted immunotoxin, in relapsed or refractory hairy cell leukemia. Blood 114, 2009 (abstr 888)
22. Goldaniga M, Guffanti A, Gianelli U, et al: Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab. Haematologica 89:ECR41, 2004
23. Busemann C, Schüler F, Krüger W, et al: Late extramedullary relapse after allogeneic transplantation in a case of variant hairy cell leukaemia. Bone Marrow Transplant 45:1117-1118, 2010